Latest News about RMD
Recent news which mentions RMD
From Benzinga
ResMed Q2 Earnings Highlights: Supply Chain Constraints, Unlimited Demand Due To Competitor Recall
January 28, 2022
From Benzinga
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
January 27, 2022
From Benzinga
Earnings Scheduled For January 27, 2022
January 27, 2022
From Benzinga
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
January 23, 2022
From Benzinga
2 Healthcare Stocks That Could Help Set You Up for Life
January 20, 2022
From Motley Fool
Even the beleaguered tech sector has winners from rising inflation. Here are some of Credit Suisse’s favorites.
January 20, 2022
From MarketWatch
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2022
January 13, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
From Benzinga
3 Stocks to Add to Your Portfolio in the Event of a Market Downturn
November 17, 2021
From Motley Fool
CNBC's Final Trades: Fiserv, ResMed, Monster Beverage And This Semiconductor Company
November 16, 2021
From Benzinga
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
From Benzinga
From Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
3 Leading Healthcare Stocks to Buy in 2021 and Beyond
October 19, 2021
From Motley Fool
3 Top Healthcare Stocks to Buy Right Now
October 13, 2021
From Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
September 30, 2021
From Motley Fool
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
From Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
Chief Administrative Officer Of Resmed Makes $434.44 Thousand Sell
September 07, 2021
Tickers
RMD
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.